Announcements Trials
Browse Landscape

Phase

Phase 2 45Phase 1 12Phase 3 9Phase 1/2 7Phase NA 5Phase EARLY_PHASE1 3Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 4Lymphoma 3Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Breast Neoplasms 2Retinoblastoma 1Recurrence 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Leukemia 1Hepatoblastoma 1Chemotherapy-Induced Febrile Neutropenia 1Burkitt Lymphoma 1

Interventions

Dexamethasone 11Lenalidomide 10Bortezomib 9Zoledronic Acid 8ixazomib 4daratumumab 4Melphalan 4tocilizumab 3Thalidomide 3Cyclophosphamide 3pomalidomide 2carfilzomib 2Prednisone 2Kyphoplasty 2Filgrastim 2Doxorubicin 2Calcium Dobesilate 2zanubrutinib 1talquetamab 1pegylated granulocyte colony-stimulating factor 1montelukast 1isatuximab 1ibrutinib 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1apixaban 1Vaccination 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Multiple Myeloma × Granulocyte Colony-Stimulating Factor × Clear all
NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Columbia University

Phase 4 Completed
60 enrolled 14 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡